Recommended for its ‘creative thinking’, Taylor Wessing LLP is highly adept at handling big-ticket litigation for a litany of patents, and is notably active in the Patents Court in relation to complex healthcare and pharmaceutical issues. Multi-jurisdictional litigator Nigel Stoate leads the practice with his wealth of experience that spans the medical devices, pharmaceutical, telecoms, chemical, and engineering industries. Matthew Royle leverages his background in molecular immunology to assist players in the pharmaceutical, biotech, and life sciences industries, whereas Mike Washbrook acts in high-calibre technology mandates. Andrew Payne is another key name to note.

Legal 500 Editorial commentary

Testimonials

Collated independently by Legal 500 research team.

  • 'They possess creative thinking and dare to challenge the status quo of the law.'

  • 'They are easy to communicate with.' 

  • ‘Taylor Wessing regularly coordinates big patent litigation projects on an outstanding level, especially for the life sciences sector.'

  • 'The reputation of the team is high and they are a clear reference when it comes to generic work.’

  • 'They are top-notch patent litigators and a clear choice when it comes to complex matters.'

  • 'Andrew Payne is excellent.'

Key clients

  • Pfizer Inc
  • Abbott
  • Ericsson
  • Shenzhen Senior Technology Materials Ltd
  • OPPO
  • Glenmark Pharmaceuticals Europe Limited
  • Viatris
  • Siemens Healthineers AG
  • Energize Games
  • Essential Pharma
  • AlveoGene
  • Theramex
  • Infinitopes

Lawyers

Next Generation Partners
Junior partners with significant recognition from clients and peers in the market and key roles on multiple matters.

Practice head

The lawyer(s) leading their teams.

Nigel Stoate

Other key lawyers

Matthew Royle, Mike Washbrook, Andrew Payne